| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| F7I1R4 | Protein CYR61; Uncharacterized protein; | CYR61; | XP_002749894.2; | 381 | marmoset |
| F7HLV8 | Uncharacterized protein; | VRK2; | NULL | 392 | marmoset |
| F7ISD9 | Ras-like protein family member 11B; Uncharacterized protein; | RASL11B; | XP_002745894.1; | 248 | marmoset |
| F6T3Y0 | F-box-like/WD repeat-containing protein TBL1XR1; Uncharacterized protein; | TBL1XR1; | XP_002759417.1; | 514 | marmoset |
| F6TG74 | Aldehyde dehydrogenase; | ALDH3A2; | NULL | 508 | marmoset |
| U3CMA3 | GTP-binding protein Rhes; | RASD2; | NULL | 266 | marmoset |
| F7I154 | Ran-binding protein 3 isoform RANBP3-b; Uncharacterized protein; | RANBP3; | XP_002761664.1; | 499 | marmoset |
| U3CCV5 | 40S ribosomal protein S7; | RPS7; | NULL | 193 | marmoset |
| F6S5D6 | PNMA-like protein 2; Uncharacterized protein; | PNMAL2; | XP_002762306.1; | 635 | marmoset |
| F7BE45 | Prostaglandin E synthase; Uncharacterized protein; | PTGES; | XP_002743420.1; | 152 | marmoset |
| F6QGU6 | Rab GDP dissociation inhibitor beta isoform 1; Uncharacterized protein; | GDI2; | XP_002750065.1; | 445 | marmoset |
| U3CL89 | Fibroblast growth factor receptor; EC 2.7.10.1; | FGFR2; | NULL | 706 | marmoset |
| U3ECB0 | Methionine--tRNA ligase, mitochondrial; | MARS2; | NULL | 593 | marmoset |
| U3F861 | NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6 isoform 3; | NDUFB6; | NULL | 97 | marmoset |
| F7GYW3 | Protein dpy-19 homolog 4; Uncharacterized protein; | DPY19L4; | XP_002759131.1; | 722 | marmoset |
| F7GBD4 | Chitinase-3-like protein 1; Uncharacterized protein; | CHI3L1; | XP_002760709.1; | 383 | marmoset |
| F7IL97 | Glioma pathogenesis-related protein 1; Uncharacterized protein; | GLIPR1; | XP_002752821.1; | 266 | marmoset |
| U3E7T0 | Beta-1,3-glucosyltransferase; | B3GALTL; | NULL | 499 | marmoset |
| U3F0F1 | Transmembrane protein 206 isoform 2; | TMEM206; | NULL | 350 | marmoset |
| U3ESA7 | Cysteine and histidine-rich protein 1 isoform 1; | CYHR1; | NULL | 362 | marmoset |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |